Global Behavior and Periodontal Disease in Down's Syndrome Patients

October 21, 2016 updated by: Carla Andreotti Damante, University of Sao Paulo

Down's Syndrome Patients Behavior Correlations to Periodontal Disease Status

This study aimed at correlating global behavior of Down's Syndrome patients to periodontal disease status.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

There is a higher prevalence and severity of periodontal disease in Down's Syndrome patients. Plaque levels in these patients are high due to poor hygiene habits. Behavior also may contribute to the overall periodontal condition.

Study Type

Observational

Enrollment (Actual)

33

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sao Paulo
      • Bauru, Sao Paulo, Brazil, 17012-901
        • Bauru School of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 52 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with a medical diagnose of Down's Syndrome

Description

Inclusion Criteria:

  • Down's Syndrome Diagnose characterized by the whole chromosomal aneuploidy 15 to 52 years
  • Absence of severe hearing loss could impair the comprehension about the dental treatment
  • Absence of severe visual loss that could impair the comprehension about the dental treatment
  • Presence of at least four teeth being one for hemiarch.
  • Diagnose of gingivitis and periodontitis
  • Absence of acute periodontal disease and necrotizing periodontal disease.

Exclusion Criteria:

  • Smokers
  • Use of alcohol
  • Menopause
  • Pregnancy
  • Absence of all teeth
  • Uncontrolled diabetes mellitus
  • Uncontrolled hyperthyroidism
  • Angina
  • Uncontrolled hypertension
  • Coagulopathy
  • Use of illicit drugs
  • Head and neck radiotherapy
  • Chemotherapy
  • Non-cooperative patients or patients with other diseases as autism.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Down's Syndrome
Behavior analysis in Down's Syndrome patients
One examiner observed global behavior of patients during a dental care session, guided by a behavioral scale.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Periodontal disease (gingivitis and periodontitis) measured by a periodontal probe and classified according to severity
Time Frame: One day
Severe periodontitis was defined by the presence of ≥ 2 interproximal sites in different teeth with clinical attachment level (CAL) ≥ 6mm and ≥1 interproximal site with pocket probing depth (PPD) ≥5mm. Moderate periodontitis was defined by the presence of ≥ 2 interproximal sites in different teeth with CAL ≥ 4mm or ≥ 2 interproximal sites in different teeth with PPD ≥5mm. Mild periodontitis was defined as ≥ 2 interproximal sites in different teeth with ≥ 3 mm CAL and ≥ 2 interproximal sites in different teeth with ≥ 4 mm PPD or at least 1 site with PPD ≥ 5 mm (20,21). Gingivitis was determined as follows: Subjects were considered healthy if presented PPD ≤3mm/BOP extent scores < 10% and with gingivitis if presented PPD ≤3mm/ bleeding on probing (BOP) extent scores >10%. Prevalence of periodontal disease was the sum of gingivitis, mild, moderate and severe periodontitis.
One day
Global behavior - observation and scoring based on a behavior scale
Time Frame: One day

Behavioral aspects: Interaction to evaluator, Communicative intention, Attention time, Response to conversation, Comprehension of concrete/no concrete situations with/without visual support, Parental interference, Acceptance of activities, Mimic, Eye contact, Participation in the dialogue (speech), Logical time sequence, Dialogue keeping, Word production

Scores: 0 - absence, 1 - strictly presented, 2 - evidently presented.

One day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

October 19, 2016

First Submitted That Met QC Criteria

October 19, 2016

First Posted (Estimate)

October 21, 2016

Study Record Updates

Last Update Posted (Estimate)

October 24, 2016

Last Update Submitted That Met QC Criteria

October 21, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Diseases

Clinical Trials on Behavior Analysis

3
Subscribe